Glucocorticoid-mediated gene suppression of rat cytokine-induced neutrophil chemoattractant CINC/gro, a member of the interleukin-8 family, through impairment of NF-kappa B activation

J Biol Chem. 1996 Jan 19;271(3):1651-9. doi: 10.1074/jbc.271.3.1651.

Abstract

The glucocorticoid dexamethasone inhibited the production of the rat cytokine-induced neutrophil chemoattractant CINC/gro, a counterpart of human melanoma growth-stimulating activity that belongs to the interleukin-8 (IL-8) family, in the normal rat kidney epithelial cell line NRK-52E stimulated with interleukin-1 beta (IL-1 beta), lipopolysaccharide, or tumor necrosis factor alpha. The accumulation of CINC/gro mRNA induced by these activators was also decreased comparably by dexamethasone. A nuclear run-on assay revealed that dexamethasone decreased the IL-1 beta-induced transcription of the CINC/gro gene. The half-life of CINC/gro mRNA transcripts did not change significantly after exposure to dexamethasone, suggesting that this glucocorticoid acts mainly at the transcriptional level. Transfection with luciferase expression vectors containing 5'-deleted and mutated CINC/gro gene sequences demonstrated that the 5'-flanking region containing the NF-kappa B binding site is involved in the IL-1 beta- and dexamethasone-induced activation and repression of the CINC/gro gene expression, respectively. Furthermore, a tandem repeat of the NF-kappa B sequence in the CINC/gro gene conferred the inducibility by IL-1 beta and suppression of luciferase activity by dexamethasone. In an electrophoretic mobility shift assay, dexamethasone diminished the IL-1 beta-induced formation of NF-kappa B complexes, which consisted of p65 and p50. Western blotting revealed that dexamethasone inhibited the IL-1 beta-induced translocation of p65 from the cytoplasm into the nucleus, while the nuclear level of NF-kappa B p50 remained almost unchanged. In addition, the degradation of I kappa B-alpha induced by IL-1 beta was not inhibited by dexamethasone. These results indicated that the suppression of the CINC/gro gene transcription by glucocorticoid occurs through the impairment of NF-kappa B activation, possibly by interference with the translocation of NF-kappa B p65 from the cytoplasm into the nucleus, thereby suppressing transactivation of the CINC/gro gene.

Publication types

  • Comparative Study

MeSH terms

  • Animals
  • Base Sequence
  • Blotting, Northern
  • Cell Division / drug effects
  • Cell Line
  • Cell Nucleus / metabolism
  • Chemokine CXCL1
  • Chemokines, CXC*
  • Chemotactic Factors / biosynthesis*
  • Chemotactic Factors / pharmacology
  • Cytokines / pharmacology*
  • Dexamethasone / pharmacology*
  • Gene Expression / drug effects*
  • Growth Inhibitors / biosynthesis*
  • Growth Inhibitors / pharmacology
  • Growth Substances / biosynthesis*
  • Growth Substances / pharmacology
  • Humans
  • Intercellular Signaling Peptides and Proteins*
  • Interleukin-1 / pharmacology
  • Interleukin-8 / biosynthesis
  • Interleukin-8 / pharmacology
  • Kidney
  • Kinetics
  • Luciferases / biosynthesis
  • Melanoma / pathology
  • Molecular Sequence Data
  • NF-kappa B / drug effects
  • NF-kappa B / metabolism*
  • Oligonucleotide Probes
  • RNA, Messenger / analysis
  • RNA, Messenger / biosynthesis
  • Rats
  • Recombinant Fusion Proteins / biosynthesis
  • Recombinant Proteins / pharmacology
  • Suppression, Genetic / drug effects*
  • Transcription, Genetic / drug effects
  • Transfection
  • Tumor Necrosis Factor-alpha / pharmacology

Substances

  • CXCL1 protein, human
  • Chemokine CXCL1
  • Chemokines, CXC
  • Chemotactic Factors
  • Cxcl1 protein, rat
  • Cytokines
  • Growth Inhibitors
  • Growth Substances
  • Intercellular Signaling Peptides and Proteins
  • Interleukin-1
  • Interleukin-8
  • NF-kappa B
  • Oligonucleotide Probes
  • RNA, Messenger
  • Recombinant Fusion Proteins
  • Recombinant Proteins
  • Tumor Necrosis Factor-alpha
  • Dexamethasone
  • Luciferases